Navigation Links
BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board
Date:10/7/2008

QUINCY, Mass., Oct. 7 /PRNewswire/ -- BioEnergy International, LLC (BioEnergy), a privately-held, biotech developer and manufacturer of next-generation, renewable biochemicals and biofuels, announces the addition of Norman R. Augustine to its Board of Advisors effective December 2008. Mr. Augustine has a record of distinguished leadership and innovation at the highest level of industry and government culminating in his role as Chairman and Chief Executive Officer of Lockheed Martin, the nation's largest aerospace/defense company.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080211/NEM085LOGO )

"I am honored and excited by Dr. Augustine joining our Board of Directors. He is a man of truly remarkable talents in science, engineering and public policy, and beyond that, a man distinguished by his service to all Americans whether as Chairman of the American Red Cross, President of the Boy Scouts or as Under Secretary of the Army," said Stephen J. Gatto, Chairman and Chief Executive Officer of BioEnergy. "We look forward to Mr. Augustine bringing his exceptional vision, experience and guidance to BioEnergy as we transform the chemicals and fuels markets with our bio-based platform."

"I believe BioEnergy's proven, disruptive, sustainable technology and strong management holds great potential," said Norman R. Augustine. "I am excited to begin working with the firm to help capitalize on this important opportunity."

Mr. Augustine is a current or former member of the Board of Directors of ConocoPhillips, Black & Decker, Proctor & Gamble and Lockheed Martin, and of the Board of Trustees of Colonial Williamsburg. He is a Regent of the University System of Maryland, Trustee Emeritus of Johns Hopkins and a former member of the Board of Trustees of MIT and Princeton, his alma mater. He is an Advisory Board member to the Department of Homeland Security, was a member of the Hart/Rudman Commission on National Security, and has served for 16 years on the President's Council of Advisors on Science and Technology. He has been presented the National Medal of Technology and received the Joint Chiefs of Staff Distinguished Public Service Award and is a five time recipient of the Department of Defense's Civilian Distinguished Service Medal.

Mr. Augustine co-authored The Defense Revolution and Shakespeare In Charge and is the author of Augustine's Laws and Augustine's Travels. He was selected by Who's Who in America and the Library of Congress as one of "Fifty Great Americans". He was Chairman and Principal Officer of the American Red Cross for nine years, Chairman of the National Academy of Engineering, President and Chairman of the Association of the United States Army, Chairman of the Aerospace Industries Association, and Chairman of the Defense Science Board. He is a former President of the American Institute of Aeronautics and Astronautics and the Boy Scouts of America. He has participated in a number of studies of future energy alternatives.

Mr. Augustine joins existing Advisory Board members Robert McFarlane and Chairman R. James Woolsey. "Having known and worked with Norm Augustine for many years, I can't think of a better resource for BioEnergy to draw upon in order to realize its vast potential," said Mr. Woolsey. "He is a most welcome addition to this exciting team."

"We've been fortunate in America to have produced leaders in each generation who combine scientific excellence and civic virtue with a prescient understanding of 'what we need most right now' to preserve growth and prosperity in our country; Norm Augustine is such a man. Bio-Energy is fortunate to have him on their board," said Robert "Bud" McFarlane, President Ronald Reagan's former National Security Advisor and fellow board member.

BioEnergy's Advisory Board advises the company's Board of Directors and management in the Company's strategic decision making process and other matters including business and organizational development, technology, policy and outreach.

About BioEnergy

Led by a world-renowned team of molecular biologists, engineers, and chemists, BioEnergy utilizes proprietary technology to advance the development of low-cost cellulosic sugars for the sustainable production of high-value specialty chemicals and renewable fuels. The company's strategic vision is to replace a barrel of crude with a pound of sugar derived from waste for the manufacture of everything from the fuel we put in our cars to the plastics and fabrics we use in our everyday lives. For more information, visit http://www.bioenergyllc.com.

Contact: Samuel G. McConnell, Sr.VP, Corporate Development

(617) 657-5200


'/>"/>
SOURCE BioEnergy International, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc.
2. Fulcrum BioEnergy Announces Plans to Build One of the First Commercial-Scale Ethanol Plants Using Municipal Solid Waste as Feedstock
3. Raj Khankari Named Bioenergy, Inc., CEO
4. Atlantica BioEnergy Task Force Unveiled
5. Bioenergy Life Science and Integrative Therapeutics, Inc. Form Exclusive Co-Marketing Alliance
6. BioEnergy International Facility Opens in Bay State
7. Biomaxx Systems Inc. Renews Membership With Bioenergy Australia
8. China Yingxia International, Inc. Appoints New Vice President of Finance
9. Chindex International, Inc. Announces Appearances at Upcoming Investor Conferences
10. Sangui BioTech International, Inc. Files Remaining Reports
11. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Feb. 4, 2016  Spherix Incorporated (Nasdaq: SPEX ... and monetization of intellectual property, today provided an update ... the Northern District of Texas ... Inter Partes Re-examination ("IPR") proceedings that ... The IPR was initiated on only certain claims of ...
(Date:2/3/2016)... , Feb. 3, 2016   ViaCyte, ... with the first pluripotent stem cell-derived islet replacement ... in clinical-stage development, today announced that ViaCyte and ... Companies of Johnson & Johnson, have agreed to ... into ViaCyte.  The agreement provides ViaCyte with an ...
(Date:2/3/2016)... Feb. 3, 2016 New Jersey Health Foundation ... $1 million for researchers in New ... research that demonstrates exciting potential.   ... for the New Jersey Health Foundation Research Grant ... these educational institutions— Princeton University, Rutgers University, Rowan ...
(Date:2/3/2016)... , Feb. 3, 2016  Silk Therapeutics, Inc., today ... round. Silk Therapeutics has now raised a total of $10.25 ... by the company. The Series A2 round was led by ... , with participation from new investors Lear Corporation and ... and Roy P. Disney ; Richard Sackler , MD, ...
Breaking Biology Technology:
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/2/2016)... Va. , Feb. 2, 2016   ... award from the U.S. Army Research Office and ... the range and sensitivity of the company,s ... Past Accounting Mission and, more generally, defense-related DNA ... DNA phenotyping capabilities (predicting appearance and ancestry from ...
(Date:2/1/2016)... Rising sales of consumer electronics ... intuitive gesture control market size ... consumer electronics coupled with new technological advancements to drive ... through 2020   --> ... advancements to drive global touchfree intuitive gesture control market ...
Breaking Biology News(10 mins):